1. M3 muscarinic acetylcholine receptor–reactive Th17 cells in primary Sjögren’s syndrome
- Author
-
Hiroyuki Takahashi, Hiromitsu Asashima, Takayuki Sumida, Shinya Hagiwara, Mizuki Yagishita, Saori Abe, Yuya Kondo, Hanae Kudo, Yuko Ono, Hiroto Tsuboi, Isao Matsumoto, and Fumika Honda
- Subjects
Adult ,Male ,0301 basic medicine ,T cell ,Epitopes, T-Lymphocyte ,Inflammation ,Autoantigens ,Epitope ,03 medical and health sciences ,0302 clinical medicine ,Antigen ,Muscarinic acetylcholine receptor ,medicine ,Humans ,Antigen-presenting cell ,Aged ,Autoantibodies ,Receptor, Muscarinic M3 ,biology ,business.industry ,ELISPOT ,General Medicine ,Middle Aged ,Prognosis ,Sjogren's Syndrome ,030104 developmental biology ,medicine.anatomical_structure ,Case-Control Studies ,030220 oncology & carcinogenesis ,Immunology ,biology.protein ,Th17 Cells ,Female ,medicine.symptom ,Antibody ,business ,Follow-Up Studies ,Research Article - Abstract
M3 muscarinic acetylcholine receptor (M3R) is one of the autoantigens associated with Sjögren’s syndrome (SS) and is localized in exocrine glands where disease-specific inflammation occurs. The inflammatory lesion is characterized by infiltration of CD4(+) T cells, including clonally expanded Th17 cells. We undertook this study to identify circulating M3R-specific Th17 cells and to determine functional properties of those cells. Using the enzyme-linked immunospot assay (ELISpot) method, we identified M3R-reactive Th17 cells in the peripheral blood of patients with primary SS (pSS). Among 10 examined pSS patients, 10 healthy subjects (HS), and 5 IgG4-related disease (IgG4-RD) patients, M3R-reactive IL-17 secreting cells were significantly increased in 5 pSS patients specifically. The most common T cell epitope, which was analyzed and confirmed by coculture of isolated CD4(+) T cells with antigen presenting cells plus M3R peptides in vitro, was peptide 83-95 of M3R. Peptide recognition was partly in an HLA-DR–restricted manner, confirmed by blocking assay. M3R-reactive Th17 cells positivity correlated with higher titers of anti-M3R antibodies, whose systemic disease activity score tended to be higher. Our studies highlight the role of tissue-specific autoantigen–derived circulating Th17 cells in pSS, for which further work might lead to antigen-specific targeted therapy.
- Published
- 2020